Panel Discussion: Advancing Regulatory Frameworks & Standards for Compliant Digital Pathology Co-Development

• How is the FDA dealing with staining, scanning and analysis in the CDx pathway?
• Foundation Models – how are we applying them and how far will we go?
• With reclassifications initiatives occurring, how can we follow this vain of policy and partnership evolution for digital pathology?

Speakers:

Benjamin Withey

Director, Commercial Diagnostics - CDx Lead

Pfizer

Staci J Kearney

Founder & Chief Executive Officer

Elevation Strategic Development

Alexander Alschuler

Director, Global Regulatory Affairs

Merck